Discover this podcast and so much more

Podcasts are free to enjoy without a subscription. We also offer ebooks, audiobooks, and so much more for just $11.99/month.

Ep #16: India's Cancer Story with Dr V. Radhakrishnan MD DM (Oncologist)

Ep #16: India's Cancer Story with Dr V. Radhakrishnan MD DM (Oncologist)

FromConversations on Public Health


Ep #16: India's Cancer Story with Dr V. Radhakrishnan MD DM (Oncologist)

FromConversations on Public Health

ratings:
Length:
38 minutes
Released:
May 19, 2021
Format:
Podcast episode

Description

Aptly called the Emperor of All Maladies, Cancer has confounded humans for at least a millennia. In India, the situation is dire. The one million cases diagnosed is only the tip of the iceberg, as many Indians die undiagnosed, misdiagnosed, in the course of outdated treatment protocols, and or simply in pain due to a woeful lack of palliative care.
Many of these deaths are preventable. The government foots a large part of medical bills but the demand is simply too much for the inadequately funded public healthcare system to bear. And that is where Non Profit Organisations, manned by dedicated medicos like Dr Venkatraman Radhakrishnan step in.
Join us as Dr Radhakrishnan expertly demystifies the cancer story in India. We discuss a plethora of subjects ranging from regulations, the state of research, social stigma, diagnosis, vaccines, the role of government, and pharma patents for critical oncology drugs to the policy changes it will require for India to script a much needed plot twist. 
Dr Venkatraman Radhakrishnan MD DM is a Professor of Medical Oncology and Paediatric Oncology at Cancer Institute, Chennai, India. He takes a keen interest in clinical trials, global health and cancer policy.

---

Send in a voice message: https://anchor.fm/publichealthconversations/message
Released:
May 19, 2021
Format:
Podcast episode

Titles in the series (20)

Conversations on Public Health aims to create a valuable repository of insights into public health by interviewing researchers, consultants, policy makers, donors, opinion shapers and health workers on a weekly basis.